Accelerating drug discovery with Systems Biology and Artificial Intelligence

We decipher drug effects on cellular signaling – one of the least understood aspects of biology, and a major point of failure for new medicines. We provide unique tools for discovery and optimization of GPCR drug candidates.



The InterAx platfrom

InterAx helps partners to accelerate and optimize hit‑to‑lead identification for GPCRs.

With Support From

Featured News

SEP 2021

SEP 2021

Early and successful completion of European Union’s H2020 Project    September 2021, Switzerland   Today, InterAx Biotech AG, a Biotech…
APR 2021

APR 2021

InterAx Biotech further strengthens its Scientific Advisory Board – welcoming Prof. Dr. Ruedi Aebersold as a member   April 2021,…
APR 2020

APR 2020

A Spanish-Swiss Liaison to fight COVID-19

Meeting Opportunities

No event found!